Merck: This Cancer-Drug Powerhouse Could Be a Core Dividend
A dividend-focused investor might overlook Merck at first glance. Yet this cancer‑drug powerhouse blends steady cash ...
This comparison shows how structure, turnover, and distributions affect after-tax performance. Learn which funds suit taxable accounts.
28,512 articlesA dividend-focused investor might overlook Merck at first glance. Yet this cancer‑drug powerhouse blends steady cash ...
Strategy shareholders approved a plan to start semi-monthly dividends on STRC preferred stock, aiming to steady price...
Occidental Petroleum climbs on an Evercore upgrade and a stronger oil backdrop, outpacing ExxonMobil and Chevron as t...
Nvidia is not just riding the AI wave—it's shaping it. This article explains why trillion reasons nvidia phenomenal, ...
The space economy is expanding faster than many investors realize. This space stock could ride the wave, driven by sm...
City leaders push incremental reforms alongside a revived mega-plan for Sunnyside Yard, arguing patience is key in a ...
Gen Z is delaying homeownership as debt burdens grow and mortgage rates stay high. A new snapshot shows tiny shares o...
Rural communities from Georgia to Arizona report dipping water pressure as data centers expand. Regulators are steppi...
A 67-year-old retiree with a $1 million nest egg weighs whether a six-figure Corvette fits into a decades-long retire...
Imagine a tech titan quietly owning a defense tech unicorn valued at $1B. This piece breaks down the implications for...
Chevron reports record cash flow and a durable dividend, reviving investor debate over its valuation in a volatile en...
In a turbulent 2026 market, CVS Health and Cigna are at the center of retirement portfolio debates. This piece weighs...